Cytotoxic effects of recombinant adenovirus p53 and cell cycle regulator genes (p21(WAF1/CIP1) and p16(CDKN4)) in human prostate cancers

Akinobu Gotoh, Chinghai Kao, Song Chu Ko, Katsuyuki Hamada, Ta Jen Liu, Leland W K Chung

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Purpose: Overexpressing or restoring the basal levels of tumor suppressor genes in cancer cells can suppress tumorigenicity of cancer cells. In this communication, we compared tumor suppressive activities of three well-defined tumor suppressive genes (p53, p21(WAF1/CIP1), and p16(CDKN2)) delivered individually to prostate cancer cells with adenoviral vector (Ad). Materials and Methods: Efficacy of growth inhibition by recombinant adenoviruses bearing p53, p21(WAF1/CIP1), or p16(CDKN2) (Ad5CMV-p53, Ad5CMV- p21, Ad5CMV-p16) genes were tested in vitro on androgen-dependent (LNCaP) and androgen-independent (C4-2, DU-145, and PC-3) human prostate cancer cells, ex vivo and in vivo on PC-3 tumor. Results: Ad5CMV-p53 was observed to exert the greatest growth inhibitory action on all of the cell lines tested; inhibition appeared to be cytolytic. In comparison to control Ad5CMV-PA added samples, the growth inhibitory action of Ad5CMV-p21 and Ad5CMV-p16 appeared to be cytostatic. Ad5CMV-p53 is more effective than Ad5CMV-p16 and Ad5CMV-p21 in inhibiting the tumor 'take' rate. A similar order of antitumor activity was observed when recombinant adenoviruses were injected intratumorily to previously established PC-3 tumors in vivo. Conclusion: p53 is the most effective tumor suppressor gene to target human prostate cancer.

Original languageEnglish (US)
Pages (from-to)636-641
Number of pages6
JournalJournal of Urology
Volume158
Issue number2
DOIs
StatePublished - Aug 1997
Externally publishedYes

Fingerprint

Cyclin-Dependent Kinase Inhibitor p21
cdc Genes
Regulator Genes
Adenoviridae
Prostatic Neoplasms
Neoplasms
Tumor Suppressor Genes
Androgens
Growth
p16 Genes
p53 Genes
Cytostatic Agents
Cell Line

Keywords

  • Gene therapy
  • P16(CDKN2)
  • P21(WAF1/CIP1)
  • P53
  • Tumor suppressor gene

ASJC Scopus subject areas

  • Urology

Cite this

Cytotoxic effects of recombinant adenovirus p53 and cell cycle regulator genes (p21(WAF1/CIP1) and p16(CDKN4)) in human prostate cancers. / Gotoh, Akinobu; Kao, Chinghai; Ko, Song Chu; Hamada, Katsuyuki; Liu, Ta Jen; Chung, Leland W K.

In: Journal of Urology, Vol. 158, No. 2, 08.1997, p. 636-641.

Research output: Contribution to journalArticle

Gotoh, Akinobu ; Kao, Chinghai ; Ko, Song Chu ; Hamada, Katsuyuki ; Liu, Ta Jen ; Chung, Leland W K. / Cytotoxic effects of recombinant adenovirus p53 and cell cycle regulator genes (p21(WAF1/CIP1) and p16(CDKN4)) in human prostate cancers. In: Journal of Urology. 1997 ; Vol. 158, No. 2. pp. 636-641.
@article{c118c0267c0145aab6ea16b776af46f1,
title = "Cytotoxic effects of recombinant adenovirus p53 and cell cycle regulator genes (p21(WAF1/CIP1) and p16(CDKN4)) in human prostate cancers",
abstract = "Purpose: Overexpressing or restoring the basal levels of tumor suppressor genes in cancer cells can suppress tumorigenicity of cancer cells. In this communication, we compared tumor suppressive activities of three well-defined tumor suppressive genes (p53, p21(WAF1/CIP1), and p16(CDKN2)) delivered individually to prostate cancer cells with adenoviral vector (Ad). Materials and Methods: Efficacy of growth inhibition by recombinant adenoviruses bearing p53, p21(WAF1/CIP1), or p16(CDKN2) (Ad5CMV-p53, Ad5CMV- p21, Ad5CMV-p16) genes were tested in vitro on androgen-dependent (LNCaP) and androgen-independent (C4-2, DU-145, and PC-3) human prostate cancer cells, ex vivo and in vivo on PC-3 tumor. Results: Ad5CMV-p53 was observed to exert the greatest growth inhibitory action on all of the cell lines tested; inhibition appeared to be cytolytic. In comparison to control Ad5CMV-PA added samples, the growth inhibitory action of Ad5CMV-p21 and Ad5CMV-p16 appeared to be cytostatic. Ad5CMV-p53 is more effective than Ad5CMV-p16 and Ad5CMV-p21 in inhibiting the tumor 'take' rate. A similar order of antitumor activity was observed when recombinant adenoviruses were injected intratumorily to previously established PC-3 tumors in vivo. Conclusion: p53 is the most effective tumor suppressor gene to target human prostate cancer.",
keywords = "Gene therapy, P16(CDKN2), P21(WAF1/CIP1), P53, Tumor suppressor gene",
author = "Akinobu Gotoh and Chinghai Kao and Ko, {Song Chu} and Katsuyuki Hamada and Liu, {Ta Jen} and Chung, {Leland W K}",
year = "1997",
month = "8",
doi = "10.1016/S0022-5347(01)64574-9",
language = "English (US)",
volume = "158",
pages = "636--641",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Cytotoxic effects of recombinant adenovirus p53 and cell cycle regulator genes (p21(WAF1/CIP1) and p16(CDKN4)) in human prostate cancers

AU - Gotoh, Akinobu

AU - Kao, Chinghai

AU - Ko, Song Chu

AU - Hamada, Katsuyuki

AU - Liu, Ta Jen

AU - Chung, Leland W K

PY - 1997/8

Y1 - 1997/8

N2 - Purpose: Overexpressing or restoring the basal levels of tumor suppressor genes in cancer cells can suppress tumorigenicity of cancer cells. In this communication, we compared tumor suppressive activities of three well-defined tumor suppressive genes (p53, p21(WAF1/CIP1), and p16(CDKN2)) delivered individually to prostate cancer cells with adenoviral vector (Ad). Materials and Methods: Efficacy of growth inhibition by recombinant adenoviruses bearing p53, p21(WAF1/CIP1), or p16(CDKN2) (Ad5CMV-p53, Ad5CMV- p21, Ad5CMV-p16) genes were tested in vitro on androgen-dependent (LNCaP) and androgen-independent (C4-2, DU-145, and PC-3) human prostate cancer cells, ex vivo and in vivo on PC-3 tumor. Results: Ad5CMV-p53 was observed to exert the greatest growth inhibitory action on all of the cell lines tested; inhibition appeared to be cytolytic. In comparison to control Ad5CMV-PA added samples, the growth inhibitory action of Ad5CMV-p21 and Ad5CMV-p16 appeared to be cytostatic. Ad5CMV-p53 is more effective than Ad5CMV-p16 and Ad5CMV-p21 in inhibiting the tumor 'take' rate. A similar order of antitumor activity was observed when recombinant adenoviruses were injected intratumorily to previously established PC-3 tumors in vivo. Conclusion: p53 is the most effective tumor suppressor gene to target human prostate cancer.

AB - Purpose: Overexpressing or restoring the basal levels of tumor suppressor genes in cancer cells can suppress tumorigenicity of cancer cells. In this communication, we compared tumor suppressive activities of three well-defined tumor suppressive genes (p53, p21(WAF1/CIP1), and p16(CDKN2)) delivered individually to prostate cancer cells with adenoviral vector (Ad). Materials and Methods: Efficacy of growth inhibition by recombinant adenoviruses bearing p53, p21(WAF1/CIP1), or p16(CDKN2) (Ad5CMV-p53, Ad5CMV- p21, Ad5CMV-p16) genes were tested in vitro on androgen-dependent (LNCaP) and androgen-independent (C4-2, DU-145, and PC-3) human prostate cancer cells, ex vivo and in vivo on PC-3 tumor. Results: Ad5CMV-p53 was observed to exert the greatest growth inhibitory action on all of the cell lines tested; inhibition appeared to be cytolytic. In comparison to control Ad5CMV-PA added samples, the growth inhibitory action of Ad5CMV-p21 and Ad5CMV-p16 appeared to be cytostatic. Ad5CMV-p53 is more effective than Ad5CMV-p16 and Ad5CMV-p21 in inhibiting the tumor 'take' rate. A similar order of antitumor activity was observed when recombinant adenoviruses were injected intratumorily to previously established PC-3 tumors in vivo. Conclusion: p53 is the most effective tumor suppressor gene to target human prostate cancer.

KW - Gene therapy

KW - P16(CDKN2)

KW - P21(WAF1/CIP1)

KW - P53

KW - Tumor suppressor gene

UR - http://www.scopus.com/inward/record.url?scp=0030757796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030757796&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(01)64574-9

DO - 10.1016/S0022-5347(01)64574-9

M3 - Article

VL - 158

SP - 636

EP - 641

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -